-
-
Call more information
660-596-2224 -
Anesthesia & Analgesia: June 2016 – Volume 122 – Issue 6 – p 2017–2027 AUTHORS: O’Neill, Liam PhD et al In this article, we consider the privacy implications of posting data from small, randomized trials, observational studies, or case series in anesthesia from a few (e.g., 1–3) hospitals. Prior to publishing such data as supplemental […]
Read MoreAnesthesia & Analgesia: May 2016 AUTHORS: Schwartz, Lawrence I. MD et al BACKGROUND: Dexmedetomidine is a selective [alpha]-2 receptor agonist with a sedative and cardiopulmonary profile that makes it an attractive anesthetic for pediatric patients with congenital heart disease (CHD). Although several smaller, single-center studies suggest that dexmedetomidine use is gaining traction in the perioperative […]
Read MoreAverage direct costs of fibromyalgia syndrome (FMS) add up to C$3804 per patient each year, new data from Canada show. Overall, the data demonstrate the substantial societal burden of the disease. A similar burden has been found in studies conducted in the United States, where the disorder affects nearly 5 million adults, according to the […]
Read MoreThe use of moderate sedation leads to better clinical outcomes compared with general anaesthesia for patients undergoing transcatheter aortic valve replacement (TAVR). Researchers conducted the largest observational study of minimally invasive transfemoral TAVR to find whether the use of moderate sedation is associated with improved patient outcomes, specifically evaluating 30-day mortality and length of hospital […]
Read MorePatients with coexistent Parkinson’s disease (PD) and cervical spondylotic myelopathy (CSM) may experience a marked reduction in pain symptoms following cervical decompression, according to results of a matched cohort-controlled retrospective review study presented at the 84th Annual Meeting of the American Association of Neurological Surgeons (AANS). Parkinson’s disease, however, when isolated as a significant independent […]
Read More